Podcasts

How to Monitor Patients With Compensated Cirrhosis

04/02/2026

This educational video featuring Dr. Rustgi reviews key updates in hepatology, including HCC surveillance in compensated cirrhosis and the emerging role of liquid biopsies for earlier, more accurate cancer detection. It highlights the limitations of traditional tools like ultrasound and AFP, while introducing advances such as circulating tumor DNA and other minimally invasive biomarkers.

The discussion also covers subclinical portal hypertension and the use of HVPG and non-invasive tools for early risk stratification, along with practical applications across patient populations, including MASLD and post-hepatitis C patients. Additionally, it explores the impact of metabolic disease and obesity on cirrhosis progression, emphasizing the need for multidisciplinary, personalized management strategies.

A concise overview for clinicians looking to stay current on evolving approaches in liver disease and HCC surveillance.